Article Reprints – Privacy

The following Pharma Marketing News reprints and case studies relating to Privacy are available.

  • California’s Physician Prescribing Act: A History of Twists and Turns
    This article traces the changes in California’s Physician Prescribing Act (AB 262) as it wended its way through various committees. It describes the provisions that may limit the use of physician prescribing data by pharmaceutical marketers, identifies organizations that have taken a position in favor and against the bill, and discusses the arguments on both sides of the issue.

    Order the REPRINT now for ONLY $6.95 (PDF file delivered to you by email):

  • The FTC-Lilly Consent Decree: What it Means for PHARMA Vendors and Partners
    The 2002 settlement between ELi Lilly and the FTC regarding ‘unauthorized disclosure of sensitive personal information collected from consumers’ has an impact beyond Lilly. It also affects its agents who collect personally identifiable information from consumers in ‘connection with the advertising, marketing, offering for sale, or sale of any pharmaceutical productÂ…’ Such agents could include interactive agencies that build and maintain Web sites, direct marketing agencies, fulfillment centers, market researchers, etc. If you are a pharmaceutical service provider, read this commentary to learn what you need to do to be compliant with privacy and security standards demanded by your pharma clients.

    Full Text – FREE! (pdf).

  • Ethical Online Practices Build Consumer Trust
    Although pharmaceutical firms claim they are not required to comply with regulations enacted under the Health Insurance Portability and Accountability Act of 1996, using HIPAA as a model for online policy may help drug companies improve their public images, build trust with consumers and, ultimately, sell more products.

    Full Text – FREE! (pdf).

  • Managing Privacy Risks in Your Commercial Practices
    Even though the privacy regulations under HIPAA (the Health Insurance Portability and Accountability Act of 1996) do not directly apply to pharmaceutical companies, HIPAA may have heightened health privacy sensitivities among consumers and health professionals. Learn what practical advice two attorneys at pharmaceutical companies have for their colleagues wishing to manage privacy risks.

    Order the REPRINT now for ONLY $6.95 (PDF file delivered to you by email):

  • Pharmaceutical Compliance with Fair Information Practice Principles
    How well do pharmaceutical companies’ privacy policies comply with best practices such as the FTC’s Fair Information Practice principles? To determine this, an analysis was performed on the privacy policies of the 21 top selling prescription products worldwide (data from 2000). The results are presented in this article.

    Full Text – FREE! (pdf).

Return to top…